These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27718521)

  • 21. Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.
    van Geel MJ; Mul K; Oostveen AM; van de Kerkhof PC; de Jong EM; Seyger MM
    Br J Dermatol; 2014 Aug; 171(2):363-9. PubMed ID: 24593129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
    Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study.
    Salman A; Yucelten AD; Sarac E; Saricam MH; Perdahli-Fis N
    An Bras Dermatol; 2018; 93(6):819-823. PubMed ID: 30484525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translation and validation of the Simplified Psoriasis Index (SPI) into Brazilian Portuguese.
    Morais MR; Martins GA; Romiti R; Tonoli RE; Carvalho AVE
    An Bras Dermatol; 2018; 93(6):813-818. PubMed ID: 30484524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice.
    Kim E; Fischer G
    Australas J Dermatol; 2021 May; 62(2):190-194. PubMed ID: 33586132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability, responsiveness and validity of Scalpdex in children with scalp psoriasis: the Dutch study.
    Oostveen AM; Jong EM; Evers AW; Donders AR; van de Kerkhof PC; Seyger MM
    Acta Derm Venereol; 2014 Mar; 94(2):198-202. PubMed ID: 24002532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters.
    Armstrong AW; Parsi K; Schupp CW; Mease PJ; Duffin KC
    JAMA Dermatol; 2013 May; 149(5):577-82. PubMed ID: 23426158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.
    Walsh JA; McFadden M; Woodcock J; Clegg DO; Helliwell P; Dommasch E; Gelfand JM; Krueger GG; Duffin KC
    J Am Acad Dermatol; 2013 Dec; 69(6):931-7. PubMed ID: 24054760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician's Global Assessment, Psoriasis Area and Severity Index and Static Physician's Global Assessment.
    Simpson MJ; Chow C; Morgenstern H; Luger TA; Ellis CN
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1415-20. PubMed ID: 25917214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey.
    Soliman M
    Clin Cosmet Investig Dermatol; 2020; 13():601-609. PubMed ID: 32943898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Severity scores for childhood psoriasis: A systematic literature review].
    Lavaud J; Mahé E
    Ann Dermatol Venereol; 2019 Dec; 146(12):771-782. PubMed ID: 31060749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative.
    Perez-Chada LM; Salame NF; Ford AR; Duffin KC; Garg A; Gottlieb AB; Latella J; Merola JF; Armstrong AW
    Am J Clin Dermatol; 2020 Jun; 21(3):323-338. PubMed ID: 31950353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Children's Dermatology Life Quality Index: validation of the cartoon version.
    Holme SA; Man I; Sharpe JL; Dykes PJ; Lewis-Jones MS; Finlay AY
    Br J Dermatol; 2003 Feb; 148(2):285-90. PubMed ID: 12588381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
    Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
    Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
    He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM).
    Salame N; Torres J; Sandhu J; Callis Duffin K; Garg A; Gottlieb AB; Latella J; Merola JF; Armstrong AW
    Dermatology; 2018; 234(3-4):112-119. PubMed ID: 31112972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
    Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
    Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychiatric symptoms and health-related quality of life in children and adolescents with psoriasis.
    Bilgic A; Bilgic Ö; Akış HK; Eskioğlu F; Kılıç EZ
    Pediatr Dermatol; 2010; 27(6):614-7. PubMed ID: 21078106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
    Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
    J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.